Condition
Psoriasis Universalis
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Unknown1
Recruiting1
Withdrawn1
Clinical Trials (3)
Showing 3 of 3 trials
NCT04950218Recruiting
Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis
NCT04099979Withdrawn
A Pilot Study to Explore the Role of Gut Flora in Psoriasis
NCT05144165Unknown
Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines
Showing all 3 trials